Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of X4 Pharmaceuticals Inc (NASDAQ: XFOR) was $0.61 for the day, up 0.66% from the previous closing price of $0.61. In other words, the price has increased by $0.66 from its previous closing price. On the day, 3.33 million shares were traded. XFOR stock price reached its highest trading level at $0.68 during the session, while it also had its lowest trading level at $0.5727.
Ratios:
Our analysis of XFOR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.80 and its Current Ratio is at 4.89. In the meantime, Its Debt-to-Equity ratio is 1.31 whereas as Long-Term Debt/Eq ratio is at 1.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 12, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $3 previously.
On December 22, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on December 22, 2022, with a $3 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 15 ’24 when Ragan Paula sold 31,897 shares for $0.39 per share. The transaction valued at 12,583 led to the insider holds 993,919 shares of the business.
Ragan Paula bought 31,897 shares of XFOR for $13,078 on Nov 15 ’24. On Oct 15 ’24, another insider, Ragan Paula, who serves as the President and CEO of the company, sold 31,897 shares for $0.56 each. As a result, the insider received 17,926 and left with 1,025,816 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XFOR now has a Market Capitalization of 104254768 and an Enterprise Value of 9242562. For the stock, the TTM Price-to-Sale (P/S) ratio is 93.70 while its Price-to-Book (P/B) ratio in mrq is 1.73. Its current Enterprise Value per Revenue stands at 16.417 whereas that against EBITDA is -0.075.
Stock Price History:
Over the past 52 weeks, XFOR has reached a high of $1.60, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is 21.88%, while the 200-Day Moving Average is calculated to be -23.36%.
Shares Statistics:
XFOR traded an average of 3.13M shares per day over the past three months and 5319360 shares per day over the past ten days. A total of 168.51M shares are outstanding, with a floating share count of 117.85M. Insiders hold about 30.90% of the company’s shares, while institutions hold 35.58% stake in the company. Shares short for XFOR as of 1730332800 were 11424210 with a Short Ratio of 4.00, compared to 1727654400 on 13562227. Therefore, it implies a Short% of Shares Outstanding of 11424210 and a Short% of Float of 6.84.
